Physician profile
Peter H Hollis
NPI 1629115308
$417,103.00
in general payments reported to CMS, 2019-2025
8 companies · $70K in 2025
The $70K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $77K · 2021: $59K · 2022: $62K · 2023: $65K · 2024: $52K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $185K · Travel and Lodging: $1,029 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $185,196.88 |
| Travel and Lodging | $1,029.18 |
| Food and Beverage | $604.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $414,517.06 | 2019-2025 | Coalition Mis / Mis Ti, Coalition Agx, Excelsiusgps Robotic Navigation System |
| 4web, INC. | $2,467.85 | 2019-2024 | Spine Truss System |
| Si-Bone, INC. | $68.83 | 2021 | |
| Zimmer Biomet Holdings, INC. | $17.51 | 2019 | |
| Abbvie INC. | $12.93 | 2023 | |
| Orthofix Medical, INC. | $12.08 | 2025 | Cervical-Stim |
| Lemaitre Vascular, INC. | $6.74 | 2023 | Anastoclip Gc 8cm (Medium) |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hollis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.